about
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanismsRegulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VIIGrowth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunctionFunctional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.The investigation of hypocalcaemia and rickets.Transcriptome-wide identification of preferentially expressed genes in the hypothalamus and pituitary glandSclerochoroidal calcification associated with Albright's hereditary osteodystrophyPlant G proteins, phytohormones, and plasticity: three questions and a speculation.Multihormonal resistance to parathyroid hormone, thyroid stimulating hormone, and other hormonal and neurosensory stimuli in patients with pseudohypoparathyroidism.Resistance to growth hormone releasing hormone and gonadotropins in Albright's hereditary osteodystrophy.Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis.Hypoparathyroidism and pseudohypoparathyroidism.Mechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases.Gαo potentiates estrogen receptor α activity via the ERK signaling pathwayUse of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathwayRegulation of heterotrimeric G protein signaling in airway smooth muscle.A novel polymorphism at the GNAS1 gene associated with low circulating calcium levels.Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy.Genodermatoses caused by genetic mosaicism.The Hippo pathway: regulators and regulations.The Association of Pseudohypoparathyroidism Type Ia with Chiari Malformation Type I: A Coincidence or a Common Link?Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone.Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.GNB3 overexpression causes obesity and metabolic syndrome.Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function.Fetal ovarian cysts: an early manifestation of McCune-Albright syndrome?Clinical heterogeneity of familial pseudohypoparathyroidism.Stage-specific effects of cAMP signaling during distal lung epithelial development.Expression and localization of the diacylglycerol kinase family and of phosphoinositide signaling molecules in adrenal gland.Avanços recentes no conhecimento dos mecanismos moleculares envolvidos na tumorigênese adrenocortical
P2860
Q28478521-29B82C95-3557-426F-827F-46EE7919C720Q28592050-0CC95FC9-8FF5-42FB-BA91-8260CA1E128CQ33840263-C6FF8A3D-4600-4B2F-AB3A-506C100509CAQ34297140-914EC018-B086-419C-AB1B-AA169691B4BFQ35011891-2B1B1304-35DB-4815-A3AE-19DC02F9296CQ35115497-F09F7C87-9942-4C3D-ABDE-6E311EA561ACQ35971350-23A69934-999C-4399-B328-9E4DA6D9C990Q35976185-4D6E2F4B-2166-42F6-B386-208D71D8093EQ35991080-DAEDBAED-40E9-4147-AFF3-98957324B3BFQ36514106-A48F8CBC-23D2-451C-9931-A91104E64A68Q36514109-42410B59-2581-4425-8F09-BC634DB05D33Q36579798-6988BA2B-DFBC-4774-A264-B81938E455E2Q36658926-AE9979E8-E228-4C77-B95E-C3CA804D4A5CQ36672702-5B06E8A2-5A28-410D-94AC-C860C55CD31EQ36734550-43741792-5DA7-4F55-A74B-0E5B73951280Q36854286-3E06BA6E-2C8B-43A4-9422-0FD0F2567A2BQ37038052-FC43E77B-07C3-4DA0-A728-E2AF8C881D01Q37430495-A7510E1D-CCE3-4AB8-9FA5-C49160346693Q37851164-1EAA4D15-C75D-416A-B07A-2E607BA1320BQ38056850-0A6DF20A-BDB7-4A92-9D14-AA6E632DAC5FQ38083640-82521B83-6ED5-40C6-A2BD-529BEBCF8BA9Q41200673-B5CA7419-069B-43C5-8080-4A819D371037Q44061725-E8EB5150-0F61-4951-873F-454066F51BE9Q44963162-48EB410A-B03C-48C3-AED7-1869FCF74787Q45074822-C56E4FFB-D1A6-4715-A45B-53B4AD9FC16BQ51113867-0EA94181-210F-4BF6-87FB-CAC4A86DC491Q51332429-8480A94D-D5A0-4518-B7FA-3C4F25BE4EF9Q53545948-92348555-DEB6-4682-9E46-A8BB52BC3004Q53595565-930F816D-F44A-4FE1-AB8D-C6498053076BQ54270421-1686D1C5-005C-4D95-B290-3F335087C9A3Q57632656-01283476-5608-4BA0-AB2E-6FA896551B9C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
G protein mutations in endocrine diseases.
@ast
G protein mutations in endocrine diseases.
@en
G protein mutations in endocrine diseases.
@nl
type
label
G protein mutations in endocrine diseases.
@ast
G protein mutations in endocrine diseases.
@en
G protein mutations in endocrine diseases.
@nl
prefLabel
G protein mutations in endocrine diseases.
@ast
G protein mutations in endocrine diseases.
@en
G protein mutations in endocrine diseases.
@nl
P2093
P356
P1476
G protein mutations in endocrine diseases.
@en
P2093
P304
P356
10.1530/EJE.0.1450543
P577
2001-11-01T00:00:00Z